Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-02 Sale | 2022-03-04 4:10 pm | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 4,849 | $12.01 | $58,236 | 238,665 (Direct) | View |
| 2021-10-25 Sale | 2021-10-26 4:33 pm | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 130,000 | $29.75 | $3,867,500 | 69,592 (Direct) | View |
| 2021-09-21 Sale | 2021-09-22 4:53 pm | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 32,500 | $23.99 | $779,533 | 199,592 (Direct) | View |
| 2021-09-10 Sale | 2021-09-14 5:12 pm | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 32,500 | $21.15 | $687,325 | 106,092 (Direct) | View |
| 2021-09-07 Sale | 2021-09-08 4:03 pm | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 5,000 | $18.3 | $91,500 | 138,592 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-02 Option Award | 2022-03-04 4:10 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 177,786 | $0 | 238,665 (Direct) | View |
| 2021-10-25 Exercise | 2021-10-26 4:33 pm | N/A 2027-02-09 | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 95,000 | $0 | 69,592 (Direct) | View |
| 2021-10-25 Exercise | 2021-10-26 4:33 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 95,000 | $3.2 | 69,592 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 4:53 pm | N/A 2022-12-11 | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 27,136 | $0 | 199,592 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 4:53 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 11,136 | $3.2 | 199,592 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 4:53 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert EVP of Research | 16,000 | $2.63 | 199,592 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-11 5:22 pm | N/A 2021-03-30 | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert Ex Vice President of Research | 40,000 | $0 | 143,592 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-11 5:22 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert Ex Vice President of Research | 40,000 | $3.02 | 143,592 (Direct) | View |
Ownership | 2021-01-04 5:58 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Huizinga Robert Bindert Ex Vice President of Research | 0 | $0 | 719,285 (Direct) | View |